digest of the pharmaceutical market
Certificate of Registration Media ЭЛ № ФС77-59568, issued by Roscomnadzor on 08.10.2014
Issue 2021_02
2021-03-01 14 views Print



According to the Digest`s Editorial office opinion, the main events of the February 2021 in Russian pharmaceutical industry are:


- staff changes in the Russian Ministry of Industry pharmaceutical department;

- Russian pharmaceutical manufacturers will be checked for compliance with GMP remotely;

- Russian manufacturer «R-PHARM» has completed the purchase of the TEVA plant;

- the Russian deputy suggested to withdraw the equipment for production of non-marked medicines;

- the regulator warned about the fraudsters attempts to sale of "medicines" against COVID-19.


These, as well all other industry month news, are in the February 2021 issue (Russian edition) of the Digest.


Best regards,

Natalia Egorova, Editor-in-Chief